Bristol Myers Squibb published a publication bringing real-world evidence to the discussion and helping quantify how diagnostic regulatory pathways influence biomarker-driven clinical trial activation and execution across Europe.
Public source
Publisher name
Public post
Pleased to have contributed to this work alongside Sarah Hersey and colleagues. The challenges of implementing biomarker-driven clinical trials under IVDR are well recog…
Company
Bristol Myers Squibb
- Industry
- Pharmaceutical Manufacturing
- Location
- Lawrence Township, US
- Company size
- 10,001+ employees
About Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
See moreLatest activity
Latest activity from Bristol Myers Squibb
51 signals
Presence & Recognition
Bristol Myers Squibb France team will depart for the 11th edition of Country 2 Country 4 Cancer from 16 to 18 September.
Research & Knowledge
Bristol Myers Squibb announced positive topline results from a registrational Phase 2 trial evaluating an investigational CAR T cell therapy in certain patients with relapsed or refractory multiple myeloma.
People
Bristol Myers Squibb General Manager Spain & Portugal Sandra Orta accepted her new role in BMS in the United States.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
MSD in the UK
MSD in the UK published the report It’s About Time: Accelerating the Cancer Patient Pathway highlighting practical examples from Cancer Alliances supporting the National Cancer Plan ambitions.
Research & Knowledge
Pfizer
Pfizer published a newly published preclinical paper showcasing the potential mechanistic rationale for combining ADCs with IO for treating cancer.
Research & Knowledge
GSK
GSK published a new Custom Content article from The Wall Street Journal by Hesham A. Abdullah, MD, MSc and Chris Sheldon, PhD, sharing their approach to oncology business development.
Research & Knowledge
Pierre Fabre Oncology
Pierre Fabre Oncology conducted a project with Laboratoires Pierre Fabre and Filière Intelligence Artificielle & Cancers in NSCLC to describe the molecular testing pathway and identify factors impacting therapeutic decisions.
Research & Knowledge
AstraZeneca